Evidence map›Paper›PMID 33444873›Full record

ReviewInternational journal of surgery (London, England)2021

Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - A review.

Catrin Sohrabi, Ginimol Mathew, Thomas Franchi, Ahmed Kerwan, Michelle Griffin, Jennick Soleil C Del Mundo, Syed Ahsan Ali, Maliha Agha, Riaz Agha

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of surgery (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 4 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 4 syntheses or guidelines pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pre-emptiveFrontiers in pharmacology · 2026
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Bridging Gaps in Long COVID Therapy: A Review.Current medicinal chemistry · 2026
    Review
  18. Review
  19. Review
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Catrin SohrabiBarts Health NHS Trust, London, United Kingdom. Electronic address: csohrabi42@gmail.com.
Ginimol MathewYork Teaching Hospital NHS Foundation Trust, York, United Kingdom.
Thomas FranchiThe University of Sheffield Medical School, Sheffield, United Kingdom.
Ahmed KerwanGKT School of Medical Education, King's College London, United Kingdom.
Michelle GriffinStanford University, Palo Alto, United States.
Jennick Soleil C Del MundoSt Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Syed Ahsan AliBarts Health NHS Trust, London, United Kingdom.
Maliha AghaIJS Publishing Group, London, United Kingdom.
Riaz AghaBarts Health NHS Trust, London, United Kingdom.
Barts Health NHS Trust · GBKing's College London · GBPalo Alto University · USSt Bartholomew's Hospital · GBUniversity of Sheffield · GBYork Teaching Hospital NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pneumonia outbreak of unknown aetiology emerged in Wuhan, China in December 2019. The causative organism was identified on 7th January 2020 as a novel coronavirus (nCoV or 2019-nCoV), later renamed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The resulting coronavirus disease (COVID-19) has infected over 88 million individuals, resulted in over 1.9 million deaths, and has led to an unprecedented impact on research activities worldwide. Extraordinary challenges have also been imposed on medical and surgical trainees following redeployment to full-time clinical duties. Moreover, the introduction of travel restrictions and strict lockdown measures have forced the closure of many institutions and laboratories working on research unrelated to the pandemic. The lockdown has similarly stifled supply chains and slowed research and development endeavours, whilst research charities have endured significant financial strains that have since reshaped the allocation and availability of funds. However, worldwide scientific adaptation to the COVID-19 pandemic has been observed through unprecedented levels of international collaboration alongside the uprise of remote telecommunication platforms. Although the long-term consequence of the COVID-19 pandemic on research and academic training is difficult to ascertain, the current crises will inevitably shape working and teaching patterns for years to come. To this end, we provide a comprehensive and critical evaluation of the impact of COVID-19 on scientific research and funding, as well as academic medical and surgical training.

Indexed as

Biomedical ResearchPandemicsChinaClinical CompetenceCOVID-19General SurgeryHumansInternational CooperationResearch Support as TopicSARS-CoV-2AcademiaCOVID-19ScienceSurgery

Identifiers

PMID33444873
PMCPMC7833269
OpenAlexW3119410748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.